Search filters

List of works by Keith C Bible

"Pseudo-progression" in advanced thyroid cancer in response to kinase inhibitor therapy.

scientific article published on 16 May 2017

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

scientific article

A One-Step Method for Protein Estimation in Biological Samples: Nitration of Tyrosine in Nitric Acid

scientific article published on 01 February 1999

A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer

scientific article published on 01 November 2019

A Phase 2 Trial of Flavopiridol (Alvocidib) and Cisplatin in Platin-Resistant Ovarian and Primary Peritoneal Carcinoma: MC0261 ⬇️

scientific article published on June 1, 2012

A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H.

scientific article

A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer

scientific article

A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors

scientific article published on 16 October 2007

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma

scientific article published on 06 June 2019

Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets

scientific article

American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

article

American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invas

scientific article published on 23 January 2017

An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer

scientific article published on 14 June 2020

Annatto constituent cis-bixin has selective antimyeloma effects mediated by oxidative stress and associated with inhibition of thioredoxin and thioredoxin reductase

scientific article

Antitumor Activity of VB-111, a Novel Antiangiogenic Virotherapeutic, in Thyroid Cancer Xenograft Mouse Models ⬇️

scientific article published on October 1, 2011

Bone metastases in thyroid cancer

scientific article published on 19 February 2020

Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress

scientific article published on 7 November 2006

Characterization of Caspase Processing and Activation in HL-60 Cell Cytosol Under Cell-free Conditions

scientific article published in Journal of Biological Chemistry

Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol.

scientific article

Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma

scientific article published on 01 July 2020

Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology Group

scientific article

Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration ⬇️

scientific article published on August 15, 1997

Development and characterization of a differentiated thyroid cancer cell line resistant to VEGFR-targeted kinase inhibitors

scientific article

Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers

scientific article published on 01 May 2012

Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers.

scientific article

Diagnosis and Management of Anaplastic Thyroid Cancer

scientific article published on 01 March 2019

Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial

scientific article published on 15 April 2013

Effect of P-glycoprotein on flavopiridol sensitivity

scientific article

Effect of thyroid hormone suppression on control of advanced well-differentiated thyroid cancer.

scientific article published in November 2017

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.

scientific article

Emergence of resistant clones in medullary thyroid cancer may not be rescued by subsequent salvage highly selective RET-inhibitor therapy

scientific article published on 14 July 2020

Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches

scientific article

Enhanced Survival in Locoregionally Confined Anaplastic Thyroid Carcinoma: A Single-Institution Experience Using Aggressive Multimodal Therapy ⬇️

scientific article published on December 16, 2010

European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium.

scientific article

Evolving molecularly targeted therapies for advanced-stage thyroid cancers

scientific article published on March 2016

Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study

scientific article

External beam radiation therapy for advanced/unresectable malignant paraganglioma and pheochromocytoma.

scientific article published on 22 November 2017

Flavopiridol binds to duplex DNA.

scientific article published in May 2000

Flavopiridol disrupts STAT3/DNA interactions, attenuates STAT3-directed transcription, and combines with the Jak kinase inhibitor AG490 to achieve cytotoxic synergy

scientific article published in January 2006

Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points.

scientific article published on 17 February 2006

Flavopiridol: a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells

scientific article published in November 1996

Foundation OneTM Genomic Interrogation of Thyroid Cancers in Patients with Metastatic Disease Requiring Systemic Therapy

scientific article published on 18 May 2020

Individualization of Therapies for Patients with Advanced Differentiated Thyroid Cancers ⬇️

scientific article published on 01 September 2012

Inhibition of mitochondrial respiration as a source of adaphostin-induced reactive oxygen species and cytotoxicity.

scientific article published on 9 January 2007

Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma

scientific article

Leveraging the immune system to treat advanced thyroid cancers

scientific article published on 20 October 2016

Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer.

scientific article published on May 2001

Management of treatment-related toxicities in advanced medullary thyroid cancer.

scientific article

Mutated BRAF and personalised medicine in differentiated thyroid cancer.

scientific article

New drugs for medullary thyroid cancer: new promises?

scientific article

OPTIMIZING LENVATINIB THERAPY IN PATIENTS WITH METASTATIC RADIOACTIVE IODINE-RESISTANT DIFFERENTIATED THYROID CANCERS.

scientific article

Operative intervention for recurrent adrenocortical cancer

scientific article published on December 2013

Pazopanib Enhances Paclitaxel-Induced Mitotic Catastrophe in Anaplastic Thyroid Cancer ⬇️

scientific article published on January 2, 2013

Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies.

scientific article published on 26 July 2013

Phase 1 trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end points.

scientific article published on August 2005

Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias

scientific article published in December 2005

Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paraganglioma.

scientific article published on 6 July 2017

Profound hair and skin hypopigmentation in an African American woman treated with the multi-targeted tyrosine kinase inhibitor pazopanib.

scientific article published in June 2010

Promises and Perils of Molecularly Targeted Therapeutics in Anaplastic Thyroid Cancer

scientific article published on 01 June 2016

Prosurvival function of the granulin-epithelin precursor is important in tumor progression and chemoresponse

scientific article published on June 2007

Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer

scientific article published on 4 May 2017

Salvage Therapy With Multikinase Inhibitors and Immunotherapy in Advanced Adrenal Cortical Carcinoma

scientific article published on 09 June 2020

Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity

scientific article

Surgical Treatment of Malignant Pheochromocytoma and Paraganglioma: Retrospective Case Series

scientific article published on 5 January 2017

Surgical resection of synchronously metastatic adrenocortical cancer

scientific article published on 05 August 2014

Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer

scientific article

Systemic therapeutic approaches to advanced thyroid cancers.

scientific article

Taking Stock of Therapeutic Progress in Metastatic Radioactive Iodine–Refractory Differentiated Thyroid Cancer: What's Next? ⬇️

scientific article published on 01 April 2013

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux

scientific article

The Nitric Acid Method for Protein Estimation in Biological Samples

The Nitric Acid Method for Protein Estimation in Biological Samples

The anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductase

scientific article

Toward improved outcomes in patients with anaplastic thyroid cancer

scientific article published on April 1, 2012

Toward predictive biomarkers of response to kinase inhibitor therapies in differentiated thyroid cancer

scientific article published on 22 June 2017

Toward predictive biomarkers of response to kinase inhibitor therapies in differentiated thyroid cancer

scientific article published on 14 June 2017

Treating advanced radioresistant differentiated thyroid cancer

scientific article published on 14 August 2012

Paulina is supported by:

About Paulina

Help